#Vaccine

The case revives painful parallels to Tuskegee and Henrietta Lacks as lawyers allege federal researchers exploited Black families in the race for an RSV vaccine.

Presented by Alliance for Aging Research {beacon} Health Care Health Care The Big Story HHS begins recruiting new vaccine advisors Health Secretary Robert F. Kennedy Jr.…

British pharma company one of biggest fallers on FTSE 100 despite better than expected financial results

DR Congo has reported more than 10,000 Ebola cases and nearly 4,900 deaths. The outbreak involves a virus for which there is no approved vaccine or specific treatment, complicating efforts to contain its spread.

The NIH has said it will pour nearly $200 million into developing cancer vaccines starting in December.

Health secretary’s effort to alter makeup of ACIP panel means no new recommendations coming – even as new vaccines are approved

Personalized Moderna and Merck vaccine, called intismeran, was made with same Nobel Prize-winning mRNA technology behind COVID-19 vaccines

It's been 20 years since Australian researchers created the world's first vaccine developed specifically to prevent cancer.

In a world-first, adding a vaccine tailored to a patient’s tumour to standard immunotherapy improved two-year recurrence-free outcomes; Tata Memorial Hospital oncologist says longer follow-up and affordability remain key questions

The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.

Centers for Disease Control and Prevention reported 4,588 cases across the country, more than double the tally in 2025

In all of our coverage of the disastrous tenure RFK Jr. has had as Secretary of HHS, we have not yet discussed a bonkers study the CDC planned to fund in Guinea-Bissau. This hepatitis B “vacc…

Six melanoma specialists said the Moderna and Merck vaccine results represent a clinically meaningful result for melanoma patients who underwent surgery.

Moderna and Merck are preparing to seek regulatory approval after their experimental melanoma vaccine delivered promising results in a late-stage clinical trial.

See what gave Denisovans their distinct look. Plus, a vaccine trial for Ebola could kick off this week in the Democratic Republic of the Congo and what makes a great climate graphic.

Long-awaited results from phase III trial show huge benefits for treatment-resistant melanoma.

The scientists involved say the results could mark a turning point in cancer treatment, bringing personalised medicine a step closer.

The study included more than 1,100 people with high-risk melanoma that had been surgically removed.

Melanoma is the most aggressive form of skin cancer causing about 2,600 deaths a year in the UK